RecruitingNCT00801333

Derivation of Induced Pluripotent Stem Cells From an Existing Collection of Human Somatic Cells

Studying Amyotrophic lateral sclerosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Hadassah Medical Organization
Principal Investigator
Benjamin E Reubinoff, MD PhD
Chairman of Department of Obstetrics & Gynecology/IVF, Hadassah Ein Kerem
Enrollment
25 enrolled
Eligibility
18 years · All sexes
Timeline
20082030

Study locations (2)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00801333 on ClinicalTrials.gov

Other trials for Amyotrophic lateral sclerosis

Additional recruiting or active studies for the same condition.

See all trials for Amyotrophic lateral sclerosis

← Back to all trials